Array Technologies, Inc. Reports Financial Results for the Second Quarter 2024 – Delivers strong results on continued gross margin strength
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 3.31 -0.1 (2.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.41 | 52 Week High | $7.27 | |||
| Open | $3.29 | 52 Week Low | $2.39 | |||
| Day High | $3.35 | P/E | N/A | |||
| Day Low | $3.28 | EPS | $-0.61 | |||
| Volume | 231,798 | |||||
